FPI-2071

N/A

Report date: 2024/03/08 17:56:32

Base Information

Drug NameFPI-2071
Drug Alias NameFPI-2071
ClassificationRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFusion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A